Valeant fails to satisfy investors in ‘female viagra’
Sprout shareholders say company has set price too high, not marketing pill properly
Allergan rejects Valeant Pharma’s ‘cut and slash’ takeover
Disappointed Valeant expected to raise cash and stock offer to drive through merger of companies with significant overlap of shareholders
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices